Coleen Glessner is Executive Vice President and Chief Quality, Compliance & Risk Officer at Emergent BioSolutions, overseeing global quality, ethics and compliance, and enterprise risk management. She brings extensive global experience across the biopharmaceutical industry, with deep expertise in highly regulated clinical and commercial environments; and, is recognized for leading large-scale organizational transformations and complex regulatory remediation initiatives. Previously, Coleen held senior leadership roles at Pfizer and served as Chief Quality Officer at Alexion Pharmaceuticals. She holds a BS from the University of Pittsburgh and an MBA from MIT.